73428-03-2 Usage
General Description
3-Nitro-2-naphthoic acid is a chemical compound with the molecular formula C11H7NO4. It is a nitro-substituted derivative of 2-naphthoic acid and is primarily used in the production of dyes, pigments, and fluorescent compounds. It is a yellow crystalline powder that is insoluble in water but soluble in organic solvents. 3-Nitro-2-naphthoic acid is also used in the synthesis of pharmaceuticals and agrochemicals and has been studied for its potential biological and pharmacological activities. It is important to handle this compound with care, as it is toxic if ingested or inhaled and can cause skin and eye irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 73428-03-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,4,2 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 73428-03:
(7*7)+(6*3)+(5*4)+(4*2)+(3*8)+(2*0)+(1*3)=122
122 % 10 = 2
So 73428-03-2 is a valid CAS Registry Number.
73428-03-2Relevant articles and documents
The Reaction of Phthalaldehydes with 3-Nitropropionates. A Simple Route to 3-Nitro-2-naphthoic Acids
Kienzle, Frank
, p. 2364 - 2369 (1980)
3-Nitro-propionates condense with phthalaldehydes and related compounds in the presence of a base to give 3-nitro-2-naphthoic acids.
NUCLEIC ACID BINDING COMPOUNDS, METHODS OF MAKING, AND USE THEREOF
-
Page/Page column 46, (2012/07/14)
The present invention relates to oligomer compounds, including dimers and trimers, formed by a disulfide, sulfinyl thio, olefin or hydrocarbon bond, or a hydrazone exchange bond between two or more monomers. Methods of making the monomers and the oligomers is also disclosed. Use of the compounds for inhibiting the activity of target RNA molecules, particularly those having a secondary structure that include a stem or stem-loop formation. Dimer compounds capable of inhibiting the activity of an HIV-1 RNA frameshifting stem-loop and a (CUG)n expanded repeat stem- loop are disclosed, as are methods of treating diseases associated with these target RNA molecules.
